Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Olin

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
American Journal of Surgery|September 1, 1974
Release of acid hydrolases in hemorrhagic shock after pretreatment with hydrocortisone in the pigP E Fredlund, B Kallum, N Nagasue, et al.
International Journal of Clinical Practice|January 22, 2010
Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trialsC H Sadowsky, M R Farlow, X Meng, et al.
Journal of the American Podiatric Medical Association|October 3, 2014
Efinaconazole 10% solution in the treatment of onychomycosis of the toenailsWarren S Joseph, Tracey C Vlahovic, Radhakrishnan Pillai, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 1, 1987
Digitized intra-operative video-fluoroscopy cholangiography. An analysis of 100 casesF T Fork, L Bååth, A Borgström, et al.
Journal of Drugs in Dermatology : JDD|January 22, 2015
Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual spaceBoni E Elewski, Richard A Pollak, Radhakrishnan Pillai, et al.
Current Medical Research and Opinion|September 11, 2010
The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's diseaseMartin R Farlow, George Grossberg, Serge Gauthier, et al.
Journal of the American Geriatrics Society|August 1, 1997
Eligibility of Alzheimer's disease clinic patients for clinical trialsL S Schneider, J T Olin, S A Lyness, et al.
International Journal of Geriatric Psychiatry|February 12, 2011
Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analysesGustavo Alva, George T Grossberg, Frederick A Schmitt, et al.
Clinical Drug Investigation|December 10, 2009
Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's diseaseJeffrey L Cummings, Martin R Farlow, Xiangyi Meng, et al.
CNS Neuroscience & Therapeutics|October 19, 2010
Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementiaFrederick A Schmitt, Martin R Farlow, Xiangyi Meng, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
American Journal of Surgery|September 1, 1974
Release of acid hydrolases in hemorrhagic shock after pretreatment with hydrocortisone in the pigP E Fredlund, B Kallum, N Nagasue, et al.
International Journal of Clinical Practice|January 22, 2010
Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trialsC H Sadowsky, M R Farlow, X Meng, et al.
Journal of the American Podiatric Medical Association|October 3, 2014
Efinaconazole 10% solution in the treatment of onychomycosis of the toenailsWarren S Joseph, Tracey C Vlahovic, Radhakrishnan Pillai, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 1, 1987
Digitized intra-operative video-fluoroscopy cholangiography. An analysis of 100 casesF T Fork, L Bååth, A Borgström, et al.
Journal of Drugs in Dermatology : JDD|January 22, 2015
Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual spaceBoni E Elewski, Richard A Pollak, Radhakrishnan Pillai, et al.
Current Medical Research and Opinion|September 11, 2010
The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's diseaseMartin R Farlow, George Grossberg, Serge Gauthier, et al.
Journal of the American Geriatrics Society|August 1, 1997
Eligibility of Alzheimer's disease clinic patients for clinical trialsL S Schneider, J T Olin, S A Lyness, et al.
International Journal of Geriatric Psychiatry|February 12, 2011
Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analysesGustavo Alva, George T Grossberg, Frederick A Schmitt, et al.
Clinical Drug Investigation|December 10, 2009
Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's diseaseJeffrey L Cummings, Martin R Farlow, Xiangyi Meng, et al.
CNS Neuroscience & Therapeutics|October 19, 2010
Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementiaFrederick A Schmitt, Martin R Farlow, Xiangyi Meng, et al.
Pageof 14